The largest database of trusted experimental protocols

Xenogen ivis 200 spectrum camera

Manufactured by PerkinElmer
Sourced in United States

The Xenogen IVIS-200 Spectrum camera is a non-invasive in vivo imaging system designed for small animal research. It utilizes bioluminescence and fluorescence imaging technologies to capture high-resolution images and quantitative data from live animals. The system is capable of real-time monitoring and visualization of biological processes within the animal model.

Automatically generated - may contain errors

3 protocols using xenogen ivis 200 spectrum camera

1

Cytotoxicity Assay for AML and MDS Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MOLM14-Luc cells or CFSE (Invitrogen) labeled primary AML samples were used for cytotoxicity assay as previously described.28 (link) In brief, targets were incubated at the indicated ratios with effector T cells for 4 or 16 h. Killing was calculated either by bioluminescence imaging on a Xenogen IVIS-200 Spectrum camera (PerkinElmer, Hopkinton, MA, USA) or by flow cytometry. For the latter, cells were harvested; Countbright beads and 7-AAD (Invitrogen) were added prior to analysis. Residual live target cells were CFSE+ 7-AAD–. For MDS, T cells were incubated with CD34-selected bone marrow at 1:1 ratio for 4 or 24 h as indicated, and cytotoxicity was then measured by flow cytometry or by fluorescence in situ hybridization using a probe to detect 5q deletion or monosomy 5 (EGR1 (5q31)/ D5S23, D5S721 (5p15.2)).
+ Open protocol
+ Expand
2

Bioluminescent Cytotoxicity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Luciferase+ Nalm6, OPM-2, and K562 cells were incubated at the indicated ratios with effector T cells for 24 hours. The killing was calculated by bioluminescence imaging (BLI) on a Xenogen IVIS-200 Spectrum camera (cat# 124262, PerkinElmer, Hopkinton, MA, USA) as a measure of residual live cells. Ten minutes prior to imaging, samples were treated with 1 µL D-luciferin (30 µg/mL, Gold Biotechnology, St. Louis, MO, USA) per 100 µL sample volume.
+ Open protocol
+ Expand
3

Assessing Nalm6 Xenograft Response to NIS+ CART Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Subcutaneous Nalm6 xenografts were established through the subcutaneous injection of 1 x 106 luciferase+ Nalm6 cells in PBS. Tumor burden was assessed by BLI using a Xenogen IVIS-200 Spectrum camera (PerkinElmer, Waltham, MA, USA) to confirm engraftment weekly after Nalm6 inoculation. Once the tumor volume reached 50 mm in diameter, mice were then randomized into groups receiving 1) UTD or 2) NIS+CART-cells (5 x106 intravenously). Weekly Imaging was performed 10 minutes after the intraperitoneal (IP) injection of 10 µL/g D-luciferin (15 mg/mL, Gold Biotechnology, St.Louis, MO, USA). Bioluminescent images were analyzed using Living Image version 4.4 (PerkinElmer, Waltham, MA, USA). One week after T-cell injection, mice were imaged both with BLI and 18F-TFB-PET/CT as described below. Mice were euthanized after the PET imaging and the experiment was concluded.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!